Patterns of Failure After Immunotherapy With Checkpoint Inhibitors Predict Durable Progression-Free Survival After Local Therapy for Metastatic Melanoma
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0672-3
Full Text
Open PDFAbstract
Available in full text
Date
July 24, 2019
Authors
Publisher
BMJ